Date Published: 15 July 2011

Role of the cell-adhesion molecule E-cadherin in embryonic stem cells

Health News from Manchester, England (UK).

The protein molecule E-cadherin that 'glues' cells together and so plays an important role in the development of cancers is also responsible for many other important functions of cells, according to a recent study at Manchester University, England.


The researchers investigated the role of the cell-adhesion molecule E-cadherin in embryonic stem (ES) cells and say their unexpected findings are important because they could lead to a better understanding of why some cancer cells are difficult to eradicate in patients and lead to new cancer treatments. As well as the expected findings associated with changes in adhesion, the team found that the protein may also regulate up to 25% of the genes within cells.

" E-cadherin is a 'glue' that keeps cells together in the body without it we would not develop beyond a bundle of cells a few days after conception," said Dr Chris Ward, who led the study in the University's School of Dentistry.

" E-cadherin is also important during cancer progression from benign to malignant states, with loss of this molecule leading to increased movement of the cells which can lead to secondary tumours within the body.

_ Whilst E-cadherin has been studied intensively there has been no research that has identified all of the genes that E-cadherin regulates. Our lab has carried out profiling of ES cells lacking E-cadherin and found this protein is responsible for regulating up to 25% of the genes within cells.

_ As well as the expected findings associated with changes in cell adhesion, we found that E-cadherin exerts an effect on a diverse range of biological functions within the cell. This unexpected result demonstrates that E-cadherin, often viewed as no more than a cell 'glue', is an important part of regulating the biology of ES cells."

The group found that E-cadherin regulates genes associated with, amongst other things, cell proliferation, cell death, metabolism of fats and sugars and the deciphering of messages received by cells from outside.

Since loss of E-cadherin is implicated in higher death rates in cancer patients and a more aggressive tumour type, the group has suggested that this molecule may have a much more important role to play in preventing tumour development.

Dr Ward added:

" Essentially, abnormal regulation of E-cadherin can lead to a significant change in a cell and this may be one of the reasons why such cells are difficult to eradicate in cancer patients. Further investigation of specific changes in these cells may lead to the development of novel treatments for cancer."

 

This study was carried out at Manchester University (England, UK) and was funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the Engineering and Physical Sciences Research Council (EPSRC), the Royal Society and the Association for International Cancer Research.


Source: Manchester University, England (UK)
http://www.manchester.ac.uk

Also in the News:

New method for treating burn infections in children - 14 Jul '11

New method defibrillates heart with much less electricity – and pain - 13 Jul '11

Apolipoprotein E Genotype - a biomarker for mild cognitive impairment ? - 13 Jul '11

Cognitive bias modification of interpretations (CBM-I) to help teenagers with Anxiety Symptoms. - 13 Jul '11

Could targeting the skin help prevent the spread of HIV? - 11 Jul '11

Ankylosing Spondylitis (AS), a common auto-immune arthritis - 10 Jul '11

Do patients think GPs should be paid for performance? (UK) - 8 Jul '11

SpiNNaker Project: ARM processor chips to mimic human brain functions - 7 Jul '11

Ask Angels: St Swithin's day if thou dost rain, For forty days it will remain, St Swithun's day if thou be fair, For forty days 'twill rain na mair'

Although care has been taken when compiling this page, the information contained might not be completely up to date. Accuracy cannot be guaranteed. This material is copyright. See terms of use.

IvyRose Holistic 2003-2018.